New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

New direct‐acting antivirals have the potential to transform the hepatitis C (HCV) treatment landscape, with rates of sustained viral response in excess of 90%. As these new agents are expensive, an important question is whether to focus on minimizing the consequences of severe liver disease, or red...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Viral Hepat
Main Authors: Harris, R. J., Martin, N. K., Rand, E., Mandal, S., Mutimer, D., Vickerman, P., Ramsay, M. E., De Angelis, D., Hickman, M., Harris, H.E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982023/
https://ncbi.nlm.nih.gov/pubmed/27025238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.12529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados